Treatment of multidrug-resistant tuberculosis: Should you try this at home?

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 10, 2004, Pages 1082-1083

  Griffith, David E ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 METHOXYFLUOROQUINOLONE; LINEZOLID; OXAZOLIDINONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

DATA ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG USE; EDITORIAL; HEALTH CENTER; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LONG TERM CARE; MEDICAL EXPERT; MORTALITY; MULTIDRUG RESISTANCE; PATIENT CARE; PATIENT CODING; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGEON; SURGICAL MORTALITY; THERAPEUTIC ERROR; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

AMBULATORY CARE; ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; PATIENT COMPLIANCE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 2442569074     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniarid and rifampin. N Engl J Med 1993;328:527-532.
2. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993;270:65-68.
3. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it. N Engl J Med 1993;328:576-578.
4. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330:1179-1184.
5. Centers for Disease Control. Reported tuberculosis in the United States, 2002. Atlanta: U.S. Department of Health and Human Services, CDC; 2003.
6. Chan ED, Laurel V, Strand MJ, Chan JF, Huynh M-LN, Goble M, Iseman MD. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004;169:1103-1109.
7. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474-481.
8. Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg. 2001;121:448-453.
9. Nelson KG, Griffith DE, Brown BA, Wallace RJ Jr. Results of operation in Mycobacterium avium-intracellulare lung disease. Ann Thorac Surg 1998;66:325-330.
10. Gosling RD, Uiso LO, Sam NE, Bongard E, Kanduma EG, Nyindo M, Morris RW, Gillespie SH. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2003;168:1342-1345.
11. Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med 2004;169:421-426.
12. Alcala L, Ruiz-Serrano MJ, Perez-Fernandez Turegano C, Garcia de Viedma D, Diaz-Infantes M, Marin-Arriaza M, Bouza E. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother 2003;47:416-417.
13. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcantara F, Sanchez E, Sarria M, Becerra M, Fawzi MC, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003;348:119-128.